KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization150,731 mln
Float16.03 mln
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.18
Reliable
Relative Strength
53
/ 100
Slightly ahead
Debt / Equity
1.29
Elevated leverage
ROE
-25.28
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 1947 and based in Seoul, Samil Pharmaceutical is a South Korean company that develops and sells a wide range of healthcare products. Its portfolio includes everyday medicines, specialty treatments, and medical devices, with a particular focus on eye care products such as drops and ointments. The company also produces consumer health items including skin patches and similar personal care goods.
